Figure 1 | Cancer Gene Therapy

Figure 1

From: Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus

Figure 1

Schematic representation of recombinant MV genomes. Vectors harbor either unmodified hemagglutinin (H) or fully retargeted H against EGFR and CD20 (listed at the bottom, middle), respectively, in combination with transgene X=EGFP or the hybrid E.coli CD/UPRT (listed at the bottom, left). Corresponding names of viruses are listed at the bottom right side.

Back to article page